Description:
The American Society of Addiction Medicine (ASAM) defines addiction as “a treatable, chronic medical disease,” yet many programs lack substance use disorder (SUD), and specifically opioid use disorder (OUD), education (The ASAM, 2020).Independent licensed practitioners (LIPs), particularly those in primary care and specialty areas other than psychiatry, often have limited training specific to the diagnosis and treatment of SUD and OUD.
The reality is that LIPs across specialty areas continually encounter individuals with SUDs and OUDs. The SAMHSA National Survey on Drug Use and Health (NSDUH) reports that 21.4% of people over the age of 12 (59.3 million) used an illicit substance in 2020. This includes 9.5 million people that misused opioids, of which 98% (9.3 million) were misusing prescription pain pills (SAMHSA, 2021). Of the 41.1 million people who reported needing substance use treatment, only 4 million people received any treatment (SAMHSA, 2021).
Prescribing buprenorphine for the treatment of OUD no longer requires a federal DATA X waiver, however prescribing this medication still carries stigma and, without a thorough understanding of the benefits of diagnosing and treating OUD with medications, it is not likely to be prescribed. Without training in the pathophysiology of OUD and pharmacology of the medications used to treat OUD, it is unlikely that practitioners will seek to identify and treat this condition. When the X-waiver was required, only about 50% of clinicians who have completed the X-waiver requirements made it a part of their practice.
There continues to be a need for informed, accessible, compassionate care for people who struggle with SUD and OUD. These modules provide LIPs with evidence-based treatment strategies and empower them with practical training that is recovery and trauma-informed. Through these CME modules, LIPs obtain the knowledge and skills to diagnose, treat, and prescribe medications for SUDs, including those for opioid use disorder (MOUD). These modules also provide the requisite OUD education required for DEA licensure.
Physician Accreditation Statement – The Purdue University College of Pharmacy is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Purdue University College of Pharmacy designates this enduring activity for a maximum of 14.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
FAQs Guide for Continuing Education Courses and Brightspace Navigation | Pharmacy Continuing Education (purdue.edu)
Once you have received your registration confirmation email: To log in, please go to https://purdue.brightspace.com/d2l/login and click on the Online Corporate and Noncredit section. You will log in with your username: This is the email address you provided when signed up for the course. Please follow the directions below to create your password.
1) Select the ONLINE CORPORATE AND NONCREDIT log-in tile
2) Select “Forgot your Password”
3) Enter Username (your email), then “Submit”
4) An email will be sent to your email allowing you to set up your password
Once you have accessed your course, make sure to look for the "Content" section within the course to access your coursework.